izpis_h1_title_alt

Patch testing with the European baseline series and 10 added allergens : single-centre study of 748 patients
ID Bizjak, Mojca (Avtor), ID Adamič, Katja (Avtor), ID Bajrović, Nisera (Avtor), ID Eržen, Renato (Avtor), ID Jošt, Maja (Avtor), ID Kopač, Peter (Avtor), ID Košnik, Mitja (Avtor), ID Lalek, Nika (Avtor), ID Zidarn, Mihaela (Avtor), ID Dinevski, Dejan (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,29 MB)
MD5: 5D11D9FDC9F18CC21B7D01AF8CC87373
URLURL - Izvorni URL, za dostop obiščite https://onlinelibrary.wiley.com/doi/10.1111/cod.14178 Povezava se odpre v novem oknu

Izvleček
Background: The European baseline series (EBS) of contact allergens is subject to change. An allergen is considered for inclusion when routine patch testing of patients with suspected contact dermatitis results in ≥0.5% prevalence rate. Objectives: We aimed to determine the frequency of sensitizations to 30 EBS allergens and 10 locally added allergens. Additionally, we assessed the strength and evolution of reactions to all tested allergens and co-reactivity of additional allergens. Methods: Patch testing with our baseline series of 40 allergens was done in 748 consecutive adults. Tests were applied to the upper back and removed by patients after 48 h. Readings were done on Day 3 (D3) and D6 or D7 (D6/7). Positive reactions fulfilled the criteria of at least one plus (+) reaction. A retrospective analysis was done. Results: Eight allergens not listed in the EBS had ≥0.5% prevalence rate (i.e., cocamidopropyl betaine, thiomersal, disperse blue mix 106/124, 2-bromo-2-nitropropane-1, 3-diol, diazolidinyl urea, propylene glycol, Compositae mix II and dexamethasone-21-phosphate), and 16.6% of positive reactions would have been missed without D6/7 readings. Conclusion: We propose further studies to evaluate whether cocamidopropyl betaine, disperse blue mix 106/124, 2-bromo-2-nitropropane-1,3-diol, diazolidinyl urea and Compositae mix II need to be added to the EBS.

Jezik:Angleški jezik
Ključne besede:clinical epidemiology, baseline series, contact sensitization, patch tests, simultaneous reactivity, allergy and immunology, diagnosis, hypersensitivity, skin tests
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2022
Št. strani:Str. 439–446
Številčenje:Vol. 87, iss. 5
PID:20.500.12556/RUL-141976 Povezava se odpre v novem oknu
UDK:616-097
ISSN pri članku:1600-0536
DOI:10.1111/cod.14178 Povezava se odpre v novem oknu
COBISS.SI-ID:112721411 Povezava se odpre v novem oknu
Datum objave v RUL:13.10.2022
Število ogledov:1029
Število prenosov:150
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Contact dermatitis
Založnik:Wiley
ISSN:1600-0536
COBISS.SI-ID:517686809 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:klinična epidemiologija, osnovna serija, kontaktna senzibilizacija, kožni testi z obliži, sočasna reaktivnost, alergija in imunologija, diagnostika, preobčutljivost, kožni testi

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj